Sticking To Nitrosamine Evaluations Deadline Is Priority For EU Regulators

Industry's Request For A Standardized Approach Has Been Set Aside

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".